Modest maternal caffeine exposure affects developing embryonic cardiovascular function and growth
Authors:
- Joseph P. TinneyJTJoseph P. Tinney
- Li J. LiuLLLi J. Liu
- Huda ElshershariHEHuda Elshershari
- Paul J. HoffmannPHPaul J. Hoffmann
- John C. RalpheJRJohn C. Ralphe
- Bradley B. KellerBKBradley B. Keller
- Kimimasa TobitaKTKimimasa Tobita
Open Access
- 1 May 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 294 (5) , H2248-H2256
Abstract
Caffeine consumption during pregnancy is reported to increase the risk of in utero growth restriction and spontaneous abortion. In the present study, we tested the hypothesis that modest maternal caffeine exposure affects in utero developing embryonic cardiovascular (CV) function and growth without altering maternal hemodynamics. Caffeine (10 mg·kg−1·day−1subcutaneous) was administered daily to pregnant CD-1 mice from embryonic days (EDs) 9.5 to 18.5 of a 21-day gestation. We assessed maternal and embryonic CV function at baseline and at peak maternal serum caffeine concentration using high-resolution echocardiography on EDs 9.5, 11.5, 13.5, and 18.5. Maternal caffeine exposure did not influence maternal body weight gain, maternal CV function, or embryo resorption. However, crown-rump length and body weight were reduced in maternal caffeine treated embryos by ED 18.5 ( P < 0.05). At peak maternal serum caffeine concentration, embryonic carotid artery, dorsal aorta, and umbilical artery flows transiently decreased from baseline at ED 11.5 ( P < 0.05). By ED 13.5, embryonic aortic and umbilical artery flows were insensitive to the peak maternal caffeine concentration; however, the carotid artery flow remained affected. By ED 18.5, baseline embryonic carotid artery flow increased and descending aortic flow decreased versus non-caffeine-exposed embryos. Maternal treatment with the adenosine A2Areceptor inhibitor reproduced the embryonic hemodynamic effects of maternal caffeine exposure. Adenosine A2Areceptor gene expression levels of ED 11.5 embryo and ED 18.5 uterus were decreased. Results suggest that modest maternal caffeine exposure has adverse effects on developing embryonic CV function and growth, possibly mediated via adenosine A2Areceptor blockade.Keywords
This publication has 48 references indexed in Scilit:
- Food sources and intakes of caffeine in the diets of persons in the United StatesJournal of the American Dietetic Association, 2005
- Differential Cardiovascular Regulatory Activities of the α1B- and α1D-Adrenoceptor SubtypesThe Journal of Pharmacology and Experimental Therapeutics, 2003
- The Role of Adenosine in Regulation of Cerebral Blood Flow During Hypoxia in the Near‐Term Fetal SheepThe Journal of Physiology, 2002
- Teratogen update: Evaluation of the reproductive and developmental risks of caffeineTeratology, 2001
- Caffeine Intake and the Risk of First-Trimester Spontaneous AbortionNew England Journal of Medicine, 2000
- Transitory expression of the A2b adenosine receptor during implantation chamber developmentDevelopmental Dynamics, 1999
- Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based studyBMJ, 1996
- Interspecies Comparison of In Vivo Caffeine Pharmacokinetics in Man, Monkey, Rabbit, Rat and MouseDrug Metabolism Reviews, 1984
- Maternal cardiovascular response to caffeine infusion in the pregnant eweAmerican Journal of Obstetrics and Gynecology, 1983
- Accumulation of caffeine and its metabolites in rat fetal brain and liverPharmacological Research Communications, 1975